TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34373988

Group type: EXPERIMENTAL
Intervention: TTM-based exercise training (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n = 60)
Number of subjects: 120
Study: 32618037

Group type: EXPERIMENTAL
Intervention: T. chebula 250 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: T. chebula 500 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34173133

Group type: EXPERIMENTAL
Intervention: Familias Unidas (intervention)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 194
Study: 32857471

Group type: EXPERIMENTAL
Intervention: SPL 25 mg/day plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: SPL 50 mg/day plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo plus topical benzoyl peroxide (BP) 2.5%
Number of subjects: 63
Study: 35293348

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids for 30 days before RAI ablation (G2)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids for 30 days after RAI ablation (G3)
Number of subjects: 85

Group type: COMPARATOR
Intervention: RAI ablation only (G1)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 85
Study: 34333734

Group type: EXPERIMENTAL
Intervention: ADAPT program (After Deployment, Adaptive Parenting Tools)
Number of subjects: 181
Study: 34468726

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MIR4453HG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KCNK17
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cataract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparative analysis on European population
Number of subjects: 0
Study: 33749220

Group type: EXPERIMENTAL
Intervention: 1% sodium hexametaphosphate (SHMP) added to a 3% hydrogen peroxide bleaching gel applied for 6 hours per night for 2 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: 3% hydrogen peroxide bleaching gel (control group)
Number of subjects: 24
Study: 32301128

Group type: EXPERIMENTAL
Intervention: Online HOPE intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35709685

Group type: EXPERIMENTAL
Intervention: (−)‐R enantiomer (RPQ)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: (+)‐S enantiomer (SPQ)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Racemic PQ (RSPQ)
Number of subjects: 36
Study: 35452415

Group type: EXPERIMENTAL
Intervention: Fibular osteotomy (FO) with joint debridement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Arthroscopic debridement (control)
Number of subjects: 88
Study: 34159469

Group type: EXPERIMENTAL
Intervention: Active Assisted Cycle Ergometer (AACE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 55
Study: 32632402

Group type: EXPERIMENTAL
Intervention: Slow coagulation TSCPC
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard pop-titrated TSCPC
Number of subjects: 78
Study: 35386728

Group type: EXPERIMENTAL
Intervention: Multimodal MRI examination under the alternating direction algorithm
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional multimodal MRI examination
Number of subjects: 64
Study: 32976224

Group type: EXPERIMENTAL
Intervention: 30 compressions and 2-second pause (30c2s)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: 50 compressions and 5-second pause (50c5s)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: 100 compressions and 10-second pause (100c10s)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Compression-only technique
Number of subjects: 517
Study: 32741251

Group type: EXPERIMENTAL
Intervention: Single task UE rowing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single task FB rowing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual task UE rowing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual task FB rowing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 0
Study: 33098441

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence study in Geneva during the first wave of the pandemic
Number of subjects: 28340

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence study in Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg
Number of subjects: 28340
Study: 36050204

Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS) therapy (40-Hz tonic SCS)
Number of subjects: 31
Study: 32406998

Group type: EXPERIMENTAL
Intervention: SYNERGY bioabsorbable polymer drug-eluting stent (BP-DES)
Number of subjects: 9006

Group type: COMPARATOR
Intervention: Durable polymer drug-eluting stent (DP-DES)
Number of subjects: 9006
Study: 32163564

Group type: EXPERIMENTAL
Intervention: OCP (ethinylestradiol 30 μg/desogestrel 150 μg or ethinylestradiol 30 μg/drospirenone 3 mg) for 12-30 days with a 5-day washout period
Number of subjects: 4116

Group type: COMPARATOR
Intervention: No OCP
Number of subjects: 4116

Group type: EXPERIMENTAL
Intervention: OCP
Number of subjects: 4116
Study: 34156449

Group type: EXPERIMENTAL
Intervention: Bacterial and viral profiles generated using 16S ribosomal RNA gene sequencing and multiplex PCR.
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Extremely randomized trees classification models for distinguishing CAP from healthy controls.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Validation using nasopharyngeal samples from influenza patients.
Number of subjects: 117
Study: 36299538

Group type: COMPARATOR
Intervention: Sham rTMS + C0
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Right rTMS + C0
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Left rTMS + C1
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Right rTMS + C1
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Left rTMS + C0
Number of subjects: 263
Study: 34658781

Group type: EXPERIMENTAL
Intervention: Neuravena® (800 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32917359

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium 110/50 μg via Breezhaler® (IND/GLY)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Salbutamol/ipratropium 2.5/0.5 mg via air driven nebulization (SAL/IPR)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Salbutamol/ipratropium (SAL/IPR)
Number of subjects: 33
Study: 36062127

Group type: EXPERIMENTAL
Intervention: Juan Bi Tang (JBT) - 3 g thrice daily for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment for 4 weeks
Number of subjects: 40
Study: 33186174

Group type: EXPERIMENTAL
Intervention: HFFnon-CE (noncontrast single-source dual-energy computed tomography)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: HFFAP (contrast-enhanced single-source dual-energy computed tomography in arterial phase)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: HFFPVP (contrast-enhanced single-source dual-energy computed tomography in portal venous phase)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: HFFEP (contrast-enhanced single-source dual-energy computed tomography in equilibrium phase)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fat concentration measured on fat (water)-based images
Number of subjects: 19
Study: 33175051

Group type: EXPERIMENTAL
Intervention: High intake of modern industrialized foods at breakfast, school break, and dinner.
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Food consumption frequency questionnaire applied to 58 overweight and obese students.
Number of subjects: 58
Study: 33449392

Group type: EXPERIMENTAL
Intervention: Lovastatin 80 mg/day
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 32482999

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 24
Study: 35077291

Group type: EXPERIMENTAL
Intervention: 10 headers
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 20 headers
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 40 headers
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 32933326

Group type: EXPERIMENTAL
Intervention: Esophageal cooling with the ensoETM® device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36210496

Group type: EXPERIMENTAL
Intervention: Balance exercises with mirror therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Balance exercises without mirror therapy (control)
Number of subjects: 38
Study: 34420061

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 21
Study: 33475737

Group type: EXPERIMENTAL
Intervention: HLA epitope-matched (HEM) platelets
Number of subjects: 49

Group type: COMPARATOR
Intervention: HLA standard antigen-matched (HSM) platelets
Number of subjects: 49

Group type: COMPARATOR
Intervention: Comparison of HEM to HSM
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Adequate 1-hour PCI
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Epitope mismatch effect on PCI
Number of subjects: 49
Study: 37167798

Group type: EXPERIMENTAL
Intervention: NPA-O2 (nasopharyngeal apnoeic oxygenation at 18 l/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: NoAO (preoxygenation only)
Number of subjects: 30
Study: 33760230

Group type: EXPERIMENTAL
Intervention: Novel percent plasma nomogram (PPN) with personalized target volume calculation
Number of subjects: 3443

Group type: COMPARATOR
Intervention: Current simplified 1992 nomogram (control)
Number of subjects: 3443
Study: 32770667

Group type: EXPERIMENTAL
Intervention: Generic (test) formulation of 10‐mg alfuzosin extended‐release tablets
Number of subjects: 33

Group type: COMPARATOR
Intervention: Branded (reference) formulation of 10‐mg alfuzosin extended‐release tablets
Number of subjects: 33
Study: 35263551

Group type: EXPERIMENTAL
Intervention: Surgical adhesive (TissuGlu) without drains
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional drainage placement
Number of subjects: 58
Study: 33273475

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen (HBsAg) testing
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Anti-hepatitis B core antibody (anti-HBc) testing
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Antibodies against hepatitis C virus (anti-HCV) testing
Number of subjects: 1458
Study: 35338062

Group type: EXPERIMENTAL
Intervention: Enhanced case management of HCV notifications (phone calls from a DoH specialist HCV nurse offering HCV management support)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard of care (no enhanced case management)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Enhanced case management of HCV notifications
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 170
Study: 32965623

Group type: EXPERIMENTAL
Intervention: MEL (3 mg) before exercise
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: EX + MEL
Number of subjects: 13

Group type: COMPARATOR
Intervention: EX + PLA
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Control + MEL
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control + PLA
Number of subjects: 13
Study: 32560181

Group type: EXPERIMENTAL
Intervention: Phe-10 g
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Phe-5 g
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 36053605

Group type: EXPERIMENTAL
Intervention: Grunting
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Stridor
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Haemoglobin <50 g/L
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Malaria
Number of subjects: 884

Group type: COMPARATOR
Intervention: Mean haemoglobin
Number of subjects: 884

Group type: COMPARATOR
Intervention: Mean mid-upper arm circumference (MUAC)
Number of subjects: 884
Study: 32717846

Group type: EXPERIMENTAL
Intervention: Private sector sanitation delivery (PSSD) of urine-diverting dry latrines with routine waste collection and maintenance
Number of subjects: 20

Group type: COMPARATOR
Intervention: Government standard delivery (GSD) of cistern-flush toilets or ventilated improved pit latrines
Number of subjects: 20
Study: 35272404

Group type: EXPERIMENTAL
Intervention: Tiaoshen acupuncture combined with psychotherapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Psychotherapy (Control)
Number of subjects: 78
Study: 32800385

Group type: EXPERIMENTAL
Intervention: High-protein group (target energy 20 kcal/kg/day, protein 1.8 g/kg/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Medium-protein group (target energy 20 kcal/kg/day, protein 0.9 g/kg/day)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: High-protein group during electrical muscle stimulation period
Number of subjects: 117

Group type: COMPARATOR
Intervention: Medium-protein group during electrical muscle stimulation period
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: High-protein group
Number of subjects: 117
Study: 34702773

Group type: EXPERIMENTAL
Intervention: Ceritinib administered for 10 days prior to tumor resection
Number of subjects: 10
Study: 32311983

Group type: EXPERIMENTAL
Intervention: Experimental group: Gastric tube pulled out 10 cm after conventional placement, no gastric juice extracted, B-ultrasonography verified placement below the esophagus or above the cardia, routine nasal feeding postoperatively.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group: Conventional gastric tube placement at a depth of 45 to 55 cm, gastric juice extracted, B-ultrasound positioned in the stomach instead of the cardia, postoperative nasal feeding nutrition provided.
Number of subjects: 80
Study: 35177528

Group type: EXPERIMENTAL
Intervention: Cervical artificial disc replacement (C‐ADR)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cervical artificial disc replacement (C‐ADR) with segmental motion categorized into groups (0° to 3°, 4° to 6°, 7°)
Number of subjects: 76
Study: 35726368

Group type: EXPERIMENTAL
Intervention: Immediate titrated intravenous oxytocin infusion and early amniotomy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Delayed amniotomy (after 4 h of oxytocin)
Number of subjects: 140
Study: 32673497

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4616

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4616
Study: 35898448

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (intramuscular testosterone cypionate 200 mg every 2 weeks for 18 months)
Number of subjects: 105
Study: 32965556

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 1118

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1118
Study: 32943721

Group type: EXPERIMENTAL
Intervention: Genetically determined increase in adiposity (BMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetically determined increased risk of AD
Number of subjects: 0
Study: 616761389

Group type: EXPERIMENTAL
Intervention: MobileKids Monster Manor
Number of subjects: 54

Group type: COMPARATOR
Intervention: Daily activity feedback (steps and active minutes) via an online program
Number of subjects: 54
Study: 36152109

Group type: COMPARATOR
Intervention: CTT (Classical Test Theory)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IRT (Item Response Theory)
Number of subjects: 0
Study: 34170923

Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer (fresh‐ET)
Number of subjects: 4510790

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer (frozen‐ET)
Number of subjects: 4510790

Group type: COMPARATOR
Intervention: Natural conception
Number of subjects: 4510790
Study: 32853242

Group type: EXPERIMENTAL
Intervention: Postpartum women
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Neonates
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Walking over 60 minutes to access healthcare
Number of subjects: 784
Study: 35386589

Group type: EXPERIMENTAL
Intervention: Virtual simulation-based Diabetes Foot Care Education (DFCE) program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 40
Study: 33298208

Group type: EXPERIMENTAL
Intervention: 1% LA supplementation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2% LA supplementation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 4% LA supplementation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6
Study: 35615957

Group type: EXPERIMENTAL
Intervention: Mindfulness with choice
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Stress mindset
Number of subjects: 183

Group type: COMPARATOR
Intervention: Mindfulness meditation
Number of subjects: 183
Study: 33429135

Group type: EXPERIMENTAL
Intervention: Incentives for non-avoidance
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Instructions to refrain from avoidance
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Social observation of non-avoidance
Number of subjects: 160

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 160
Study: 32969374

Group type: EXPERIMENTAL
Intervention: Emergency Caesarean Section
Number of subjects: 340

Group type: COMPARATOR
Intervention: Elective Caesarean Section
Number of subjects: 340
Study: 33740332

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex (with different concentrations of antioxidants)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 32332591

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 34
Study: 36242924

Group type: EXPERIMENTAL
Intervention: Fatigue induction with modality incompatible dual-task (90-min intervention)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fatigue induction with modality compatible dual-task (90-min intervention)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Passive control group (90-min pause)
Number of subjects: 45
Study: 34581617

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 227

Group type: COMPARATOR
Intervention: Open gastrectomy
Number of subjects: 227
Study: 32817282

Group type: EXPERIMENTAL
Intervention: MBN-signature (based on MYC, BCL-2, and NFKBIA)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Bortezomib in the MBN Sig-high subgroup
Number of subjects: 186

Group type: COMPARATOR
Intervention: Standard chemoimmunotherapy
Number of subjects: 186
Study: 34916072

Group type: COMPARATOR
Intervention: 15-minute intermittent Pringle maneuver
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: 25-minute intermittent Pringle maneuver
Number of subjects: 344
Study: 33460963

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ipilimumab/Nivolumab
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pembrolizumab/Axitinib
Number of subjects: 11
Study: 32767163

Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunitinib or Pazopanib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenvatinib + Everolimus
Number of subjects: 0
Study: 34839753

Group type: EXPERIMENTAL
Intervention: Motivational coaching
Number of subjects: 57

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 57
Study: 33998553

Group type: EXPERIMENTAL
Intervention: prisms/constant training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: prisms/variable training
Number of subjects: 60

Group type: COMPARATOR
Intervention: sham goggles/constant training
Number of subjects: 60

Group type: COMPARATOR
Intervention: sham goggles/variable training
Number of subjects: 60
Study: 34455642

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 33728346

Group type: EXPERIMENTAL
Intervention: 6-month combined aerobic and strength exercise training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 22
Study: 34516433

Group type: EXPERIMENTAL
Intervention: Usual conservative care plus a hip brace
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual conservative care
Number of subjects: 38
Study: 34051909

Group type: EXPERIMENTAL
Intervention: COACHES in Schools program
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 61
Study: 34185225

Group type: EXPERIMENTAL
Intervention: 8-item University of Washington concerns about pain (UWCAP)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: 9-item University of Washington pain-related self-efficacy (UWPRSE)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: UWCAP
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Change scores and effect sizes across treatment response categories
Number of subjects: 241
Study: 34550930

Group type: EXPERIMENTAL
Intervention: Subfascial breast augmentation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Subglandular breast augmentation
Number of subjects: 20
Study: 35634285

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2-mRNA booster vaccination
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2-mRNA primary vaccination
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2-mRNA vaccination in IBD patients treated with TNF-α inhibitors
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (66 patients)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: MM patients
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: SOT patients
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: IBD patients
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: S1-specific IgG levels
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: CD19+ B-cell counts
Number of subjects: 263